This study investigates whether intensively lowering systolic blood pressure with FDA-approved medications can reduce the buildup of amyloid and tau proteins in the brain—hallmarks of Alzheimer's disease. The trial enrolls adults aged 60-85 with high blood pressure who are cognit…
Phase: PHASE2 • Sponsor: Rong Zhang • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC